Molecular mechanisms of neonatal brain injury

Neurology Research International

Volumn 2012, Issue , 2012, Pages

  Thornton, Claire ^a   Rousset, Catherine I ^a   Kichev, Anton ^a   Miyakuni, Yasuka ^a   Vontell, Regina ^a   Baburamani, Ana A ^b   Fleiss, Bobbi ^a,c   Gressens, Pierre ^a,c,d   Hagberg, Henrik ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866184543     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2012/506320     Document Type: Review

References (204)

1. Johnston M. V., Hagberg H., Sex and the pathogenesis of cerebral palsy. Developmental Medicine and Child Neurology 2007 49 1 74 78 2-s2.0-33847071714 10.1017/S0012162207000199.x (Pubitemid 46332047)
2. Vannucci S. J., Hagberg H., Hypoxia-ischemia in the immature brain. Journal of Experimental Biology 2004 207 18 3149 3154 2-s2.0-4644236077 10.1242/jeb.01064 (Pubitemid 39275289)
3. Dommergues M. A., Patkai J., Renauld J. C., Evrard P., Gressens P., Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Annals of Neurology 2000 47 1 54 63 2-s2.0-0033976956 10.1002/1531-8249(200001)47:154::AID-ANA10>3.0.CO;2-Y (Pubitemid 30033650)
4. Eklind S., Mallard C., Leverin A. L., Gilland E., Blomgren K., Mattsby-Baltzer I., Hagberg H., Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. European Journal of Neuroscience 2001 13 6 1101 1106 2-s2.0-0035064940 10.1046/j.0953-816X.2001.01474.x (Pubitemid 32275747)
5. Gidday J. M., Fitzgibbons J. C., Shah A. R., Park T. S., Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neuroscience Letters 1994 168 1-2 221 224 2-s2.0-0028221633 10.1016/0304- 3940(94)90455-3 (Pubitemid 24097362)
6. Gonzalez F. F., Ferriero D. M., Neuroprotection in the Newborn Infant. Clinics in Perinatology 2009 36 4 859 880 2-s2.0-70450200545 10.1016/j.clp.2009.07.013
7. van Velthoven C. T. J., Kavelaars A., van Bel F., Heijnen C. J., Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. Journal of Neuroscience 2010 30 28 9603 9611 2-s2.0-77954736319 10.1523/JNEUROSCI.1835-10.2010
8. Blumberg R. M., Cady E. B., Wigglesworth J. S., McKenzie J. E., Edwards A. D., Relation between delayed impairment of cerebral energy metabolism and infarction following transient focal hypoxia-ischaemia in the developing brain. Experimental Brain Research 1997 113 1 130 137 2-s2.0-0031026883 10.1007/BF02454148 (Pubitemid 27039298)
9. Gilland E., Bona E., Hagberg H., Temporal changes of regional glucose use, blood flow, and microtubule- associated protein 2 immunostaining after hypoxia-ischemia in the immature rat brain. Journal of Cerebral Blood Flow and Metabolism 1998 18 2 222 228 2-s2.0-0031916441 (Pubitemid 28082520)
10. Lorek A., Takei Y., Cady E. B., Wyatt J. S., Penrice J., Edwards A. D., Peebles D., Wylezinska M., Owen-Reece H., Kirkbride V., Cooper C. E., Aldridge R. F., Roth S. C., Brown G., Delpy D. T., Reynolds E. O. R., Delayed (secondary) cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatric Research 1994 36 6 699 706 2-s2.0-0028079731 (Pubitemid 24357779)
11. Azzopardi D., Wyatt J. S., Cady E. B., Delpy D. T., Baudin J., Stewart A. L., Hope P. L., Hamilton P. A., Reynolds E. O. R., Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy. Pediatric Research 1989 25 5 445 451 2-s2.0-0024521338 (Pubitemid 19128271)
12. Roth S. C., Baudin J., Cady E., Johal K., Townsend J. P., Wyatt J. S., Reynolds E. O. R., Stewart A. L., Relation of deranged neonatal cerebral oxidative metabolism with neurodevelopmental outcome and head circumference at 4 years. Developmental Medicine and Child Neurology 1997 39 11 718 725 2-s2.0-0030661992 (Pubitemid 27488564)
13. Thoresen M., Penrice J., Lorek A., Cady E. B., Wylezinska M., Kirkbride V., Cooper C. E., Brown G. C., Edwards A. D., Wyatt J. S., Reynolds E. O. R., Mild hypothermia after severe transient hypoxia-ischemia ameliorates delayed cerebral energy failure in the newborn piglet. Pediatric Research 1995 37 5 667 670 2-s2.0-0028910724
14. Edwards A. D., Brocklehurst P., Gunn A. J., Halliday H., Juszczak E., Levene M., Strohm B., Thoresen M., Whitelaw A., Azzopardi D., Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010 340, article c363 2-s2.0-77449134868 10.1136/bmj.c363
15. Bereiter-Hahn J., Voth M., Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microscopy Research and Technique 1994 27 3 198 219 2-s2.0-0028047262 (Pubitemid 24062014)
16. DiMauro S., Schon E. A., Mitochondrial disorders in the nervous system. Annual Review of Neuroscience 2008 31 91 123 2-s2.0-48249156188 10.1146/annurev.neuro.30.051606.094302
17. Dubinsky J. M., Heterogeneity of nervous system mitochondria: location, location, location! Experimental Neurology 2009 218 2 293 307 2-s2.0-67649814648 10.1016/j.expneurol.2009.05.020
18. Rintoul G. L., Reynolds I. J., Mitochondrial trafficking and morphology in neuronal injury. Biochimica et Biophysica Acta 2010 1802 1 143 150 2-s2.0-71849085539 10.1016/j.bbadis.2009.09.005
19. Kucharczyk R., Zick M., Bietenhader M., Rak M., Couplan E., Blondel M., Caubet S. D., di Rago J. P., Mitochondrial ATP synthase disorders: molecular mechanisms and the quest for curative therapeutic approaches. Biochimica et Biophysica Acta 2009 1793 1 186 199 2-s2.0-56349168862 10.1016/j.bbamcr.2008.06. 012
20. Schon E. A., Area-Gomez E., Is Alzheimer's disease a disorder of mitochondria-associated membranes? Journal of Alzheimer's Disease 2010 20 2 S281 S292 2-s2.0-77956203927 10.3233/JAD-2010-100495
21. Baron M., Kudin A. P., Kunz W. S., Mitochondrial dysfunction in neurodegenerative disorders. Biochemical Society Transactions 2007 35 5 1228 1231 2-s2.0-36749037338 10.1042/BST0351228 (Pubitemid 350206468)
22. Jornayvaz F. R., Shulman G. I., Regulation of mitochondrial biogenesis. Essays in Biochemistry 2010 47 69 84
23. Reznick R. M., Zong H., Li J., Morino K., Moore I. K., Yu H. J., Liu Z. X., Dong J., Mustard K. J., Hawley S. A., Befroy D., Pypaert M., Hardie D. G., Young L. H., Shulman G. I., Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metabolism 2007 5 2 151 156 2-s2.0-33846580517 10.1016/j.cmet.2007.01.008 (Pubitemid 46172924)
24. Barsukova A. G., Bourdette D., Forte M., forte@ohsu.edu Mitochondrial calcium and its regulation in neurodegeneration induced by oxidative stress. European Journal of Neuroscience 2011 34 3 437 447 10.1111/j.1460-9568.2011. 07760.x
25. Schon E., Przedborski S., sp30@columbia.edu Mitochondria: The Next (Neurode)Generation. Neuron 2011 70 6 1033 1053 10.1016/j.neuron.2011.06.003
26. Azzopardi D., Wyatt J. S., Hamilton P. A., Cady E. B., Delpy D. T., Hope P. L., Reynolds E. O. R., Phosphorus metabolites and intracellular pH in the brains of normal and small for gestational age infants investigated by magnetic resonance spectroscopy. Pediatric Research 1989 25 5 440 444 2-s2.0-0024536219 (Pubitemid 19128270)
27. O'Brien F. E., Iwata O., Thornton J. S., De Vita E., Sellwood M. W., Iwata S., Sakata Y. S., Charman S., Ordidge R., Cady E. B., Wyatt J. S., Robertson N. J., Delayed whole-body cooling to 33 or 35°C and the development of impaired energy generation consequential to transient cerebral hypoxia-ischemia in the newborn piglet. Pediatrics 2006 117 5 1549 1559 2-s2.0-33646846602 10.1542/peds.2005-1649 (Pubitemid 46071381)
28. Vannucci S. J., Maher F., Koehler E., Simpson I. A., Altered expression of GLUT-1 and GLUT-3 glucose transporters in neurohypophysis of water-deprived or diabetic rats. American Journal of Physiology 1994 267 4, part 1 E605 E611 2-s2.0-0028156613
29. Wyatt J. S., Edwards A. D., Azzopardi D., Reynolds E. O. R., Magnetic resonance and near infrared spectroscopy for investigation of perinatal hypoxic-ischaemic brain injury. Archives of Disease in Childhood 1989 64 7 953 963 2-s2.0-0024344707 (Pubitemid 19177614)
30. Dirnagl U., Iadecola C., Moskowitz M. A., Pathobiology of ischaemic stroke: an integrated view. Trends in Neurosciences 1999 22 9 391 397 2-s2.0-0033199996 10.1016/S0166-2236(99)01401-0 (Pubitemid 29453643)
31. Hagberg H., Mallard C., Rousset Catherine C. I., Wang X., Apoptotic mechanisms in the immature Brain: involvement of mitochondria. Journal of Child Neurology 2009 24 9 1141 1146 2-s2.0-70349315125 10.1177/0883073809338212
32. Hagberg H., Rousset C., Savman K., Mallard C., Hypoxic-ischemic brain injury: apoptotic and inflammatory mechanisms. Mechanisms of Hypoxic Brain Injury in the Newborn and Potential Strategies for Neuroprotection 2007 Trivandrum, India Transworld Research Network 35 55
33. Hagberg H., Mitochondrial impairment in the developing brain after hypoxia-ischemia. Journal of Bioenergetics and Biomembranes 2004 36 4 369 373 2-s2.0-10244229166 10.1023/B:JOBB.0000041770.00567.4f (Pubitemid 39619843)
34. Carling D., AMP-activated protein kinase: balancing the scales. Biochimie 2005 87 1 87 91 2-s2.0-14544271907 10.1016/j.biochi.2004.10.017 (Pubitemid 40298770)
35. Jäer S., Handschin C., St-Pierre J., Spiegelman B. M., AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1 α Proceedings of the National Academy of Sciences of the United States of America 2007 104 29 12017 12022 2-s2.0-34547545892 10.1073/pnas.0705070104 (Pubitemid 47185622)
36. Scarpulla R. C., rsc248@northwestern.edu Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochimica et Biophysica Acta 2011 1813 7 1269 1278 10.1016/j.bbamcr.2010.09.019
37. Hawley S. A., Boudeau J., Reid J. L., Mustard K. J., Udd L., Mäkelä T. P., Alessi D. R., Hardie D. G., Complexes between the LKB1 tumor suppressor, STRAD α / β and MO25 α / β are upstream kinases in the AMP-activated protein kinase cascade. Journal of Biology 2003 2 4, article 28 2-s2.0-0345107247
38. Hawley S. A., Pan D. A., Mustard K. J., Ross L., Bain J., Edelman A. M., Frenguelli B. G., Hardie D. G., Calmodulin-dependent protein kinase kinase- β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metabolism 2005 2 1 9 19 2-s2.0-23044432463 10.1016/j.cmet.2005.05.009 (Pubitemid 43239821)
39. Hurley R. L., Anderson K. A., Franzone J. M., Kemp B. E., Means A. R., Witters L. A., The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. The Journal of Biological Chemistry 2005 280 32 29060 29066 2-s2.0-23844471263 10.1074/jbc.M503824200 (Pubitemid 41161355)
40. Woods A., Dickerson K., Heath R., Hong S. P., Momcilovic M., Johnstone S. R., Carlson M., Carling D., Ca2+/calmodulin-dependent protein kinase kinase- β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metabolism 2005 2 1 21 33 2-s2.0-23044437445 10.1016/j.cmet.2005.06.005 (Pubitemid 43239822)
41. Woods A., Johnstone S. R., Dickerson K., Leiper F. C., Fryer L. G. D., Neumann D., Schlattner U., Wallimann T., Carlson M., Carling D., LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Current Biology 2003 13 22 2004 2008 2-s2.0-10744230065 10.1016/j.cub.2003.10.031 (Pubitemid 37425212)
42. Mesplès B., Plaisant F., Fontaine R. H., Gressens P., Pathophysiology of neonatal brain lesions: lessons from animal models of excitotoxicity. Acta Paediatrica, International Journal of Paediatrics 2005 94 2 185 190 2-s2.0-14844320609 10.1080/08035250410022378 (Pubitemid 40343693)
43. Concannon C. G., Tuffy L. P., Weisová P., Bonner H. P., Dávila D., Bonner C., Devocelle M. C., Strasser A., Ward M. W., Prehn J. H. M., AMP kinase-mediated activation of the BH3-only protein Bim couples energy depletion to stressinduced apoptosis. Journal of Cell Biology 2010 189 1 83 94 2-s2.0-77950591718 10.1083/jcb.200909166
44. Gusarova G. A., Trejo H. E., Dada L. A., Briva A., Welch L. C., Hamanaka R. B., Mutlu G. M., Chandel N. S., Prakriya M., Sznajder J. I., j-sznajder@northwestern.edu Hypoxia leads to Na,K-ATPase downregulation via Ca2+ release-activated Ca2+ channels and AMPK activation. Molecular and Cellular Biology 2011 31 17 3546 3556 10.1128/MCB.05114-11
45. Mungai P. T., Waypa G. B., Jairaman A., Prakriya M., Dokic D., Ball M. K., Schumacker P. T., p-schumacker@northwestern.edu Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium release-activated calcium channels. Molecular and Cellular Biology 2011 31 17 3531 3545 10.1128/MCB.05124-11
46. Li J., Zeng Z., Viollet B., Ronnett G. V., McCullough L. D., Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke 2007 38 11 2992 2999 2-s2.0-35649019733 10.1161/STROKEAHA.107.490904 (Pubitemid 350035695)
47. McCullough L. D., Zeng Z., Li H., Landree L. E., McFadden J., Ronnett G. V., Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. The Journal of Biological Chemistry 2005 280 21 20493 20502 2-s2.0-20144368904 10.1074/jbc.M409985200 (Pubitemid 40776749)
48. Tanaka A., Youle R. J., A chemical inhibitor of DRP1 uncouples mitochondrial fission and apoptosis. Molecular Cell 2008 29 4 409 410 2-s2.0-39549092425 10.1016/j.molcel.2008.02.005 (Pubitemid 351282545)
49. Cassidy-Stone A., Chipuk J. E., Ingerman E., Song C., Yoo C., Kuwana T., Kurth M. J., Shaw J. T., Hinshaw J. E., Green D. R., Nunnari J., Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Developmental Cell 2008 14 2 193 204 2-s2.0-38849099158 10.1016/j.devcel.2007.11.019 (Pubitemid 351189177)
50. Vila M., Przedborski S., Targeting programmed cell death in neurodegenerative diseases. Nature Reviews Neuroscience 2003 4 5 365 375 2-s2.0-0038205745 10.1038/nrn1100 (Pubitemid 37280175)
51. Green D. R., Apoptotic pathways: paper wraps stone blunts scissors. Cell 2000 102 1 1 4 2-s2.0-0034616946
52. Li L. Y., Luo X., Wang X., Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001 412 6842 95 99 2-s2.0-0035811496 10.1038/35083620 (Pubitemid 32851517)
53. Susin S. A., Lorenzo H. K., Zamzami N., Marzo I., Snow B. E., Brothers G. M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D. R., Aebersold R., Siderovski D. P., Penninger J. M., Kroemer G., Molecular characterization of mitochodrial apoptosis-inducing factor. Nature 1999 397 6718 441 446 2-s2.0-0033521741 10.1038/17135
54. Troy C. M., Akpan N., Jean Y. Y., Regulation of caspases in the nervous system: implications for functions in health and disease. Progress in Molecular Biology and Translational Science 2011 99 265 305 10.1016/B978-0-12-385504-6. 00007-5
55. Bratton S. B., Salvesen G. S., Regulation of the Apaf-1-caspase-9 apoptosome. Journal of Cell Science 2010 123 19 3209 3214 2-s2.0-77956908962 10.1242/jcs.073643
56. Broughton B. R. S., Reutens D. C., Sobey C. G., Apoptotic mechanisms after cerebral ischemia. Stroke 2009 40 5 e331 e339 2-s2.0-65549098614 10.1161/STROKEAHA.108.531632
57. Bulat N., Widmann C., Caspase substrates and neurodegenerative diseases. Brain Research Bulletin 2009 80 4-5 251 267 2-s2.0-70349427008 10.1016/j.brainresbull.2009.07.007
58. Fan T.-J., tjfan@ouc.edu.cn Han L.-H., Cong R.-S., Liang J., Caspase family proteases and apoptosis. Acta Biochimica et Biophysica Sinica 2005 37 11 719 727 10.1111/j.1745-7270.2005.00108.x (Pubitemid 44890981)
59. Northington F. J., frances@jhmi.edu Chavez-Valdez R., Martin L. J., martinl@jhmi.edu Neuronal cell death in neonatal hypoxia-ischemia. Annals of Neurology 2011 69 5 743 758 10.1002/ana.22419
60. Zhu C., Wang X., Xu F., Bahr B. A., Shibata M., Uchiyama Y., Hagberg H., Blomgren K., The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death and Differentiation 2005 12 2 162 176 2-s2.0-13544277142 10.1038/sj.cdd.4401545 (Pubitemid 40220647)
61. Leonard J. R., Klocke B. J., D'sa C., Flavell R. A., Roth K. A., Strain-dependent neurodevelopmental abnormalities in caspase-3-deficient mice. Journal of Neuropathology and Experimental Neurology 2002 61 8 673 677 2-s2.0-0036327243 (Pubitemid 34851770)
62. West T., Atzeva M., Holtzman D. M., Caspase-3 deficiency during development increases vulnerability to hypoxic-ischemic injury through caspase-3-independent pathways. Neurobiology of Disease 2006 22 3 523 537 2-s2.0-33744805129 10.1016/j.nbd.2005.12.017 (Pubitemid 43832124)
63. Wang X., Karlsson J. O., Zhu C., Bahr B. A., Hagberg H., Blomgren K., Caspase-3 activation after neonatal rat cerebral hypoxia-ischemia. Biology of the Neonate 2001 79 3-4 172 179 2-s2.0-0035082808 10.1159/000047087 (Pubitemid 32247082)
64. D'Amelio M., Cavallucci V., Cecconi F., Neuronal caspase-3 signaling: not only cell death. Cell Death and Differentiation 2010 17 7 1104 1114 2-s2.0-77953613803 10.1038/cdd.2009.180
65. Monnier P. P., D'Onofrio P. M., Magharious M., Hollander A. C., Tassew N., Szydlowska K., Tymianski M., Koeberle P. D., pmonnier@uhnres.utoronto.ca Involvement of caspase-6 and caspase-8 in neuronal apoptosis and the regenerative failure of injured retinal ganglion cells. Journal of Neuroscience 2011 31 29 10494 10505 10.1523/JNEUROSCI.0148-11.2011
66. Akpan N., nea2107@columbia.edu Serrano-Saiz E., Zacharia B. E., Otten M. L., Ducruet A. F., Snipas S. J., Liu W., Velloza J., Cohen G., Sosunov S. A., Frey W. H., Salvesen G. S., Connolly E. S. Jr., Troy C. M., Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke. Journal of Neuroscience 2011 31 24 8894 8904 10.1523/JNEUROSCI.0698-11.2011
67. Nikolaev A., McLaughlin T., O'Leary D. D. M., Tessier-Lavigne M., APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009 457 7232 981 989 2-s2.0-60549089207 10.1038/nature07767
68. Chipuk J. E., Green D. R., How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends in Cell Biology 2008 18 4 157 164 2-s2.0-41149152733 10.1016/j.tcb.2008.01.007
69. Rasola A., Sciacovelli M., Pantic B., Bernardi P., Signal transduction to the permeability transition pore. FEBS Letters 2010 584 10 1989 1996 2-s2.0-77952671613 10.1016/j.febslet.2010.02.022
70. Schinzel A. C., Takeuchi O., Huang Z., Fisher J. K., Zhou Z., Rubens J., Hetz C., Danial N. N., Moskowitz M. A., Korsmeyer S. J., Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proceedings of the National Academy of Sciences of the United States of America 2005 102 34 12005 12010 2-s2.0-24744460273 10.1073/pnas.0505294102 (Pubitemid 41291119)
71. Wang X., Carlsson Y., Basso E., Zhu C., Rousset C. I., Rasola A., Johansson B. R., Blomgren K., Mallard C., Bernardi P., Forte M. A., Hagberg H., Developmental shift of cyclophilin D contribution to hypoxic-ischemic brain injury. Journal of Neuroscience 2009 29 8 2588 2596 2-s2.0-61449100405 10.1523/JNEUROSCI.5832-08.2009
72. Gibson M. E., Byung H. H., Choi J., Knudson C. M., Korsmeyer S. J., Parsadanian M., Holtzman D. M., BAX contributes to apoptotic-like death following neonatal hypoxia-ischemia: evidence for distinct apoptosis pathways. Molecular Medicine 2001 7 9 644 655 2-s2.0-0035718736 (Pubitemid 34175293)
73. Ness J. M., Harvey C. A., Strasser A., Bouillet P., Klocke B. J., Roth K. A., Selective involvement of BH3-only Bcl-2 family members Bim and Bad in neonatal hypoxia-ischemia. Brain Research 2006 1099 1 150 159 2-s2.0-33746190620 10.1016/j.brainres.2006.04.132 (Pubitemid 44088651)
74. Yin W., Cao G., Johnnides M. J., Signore A. P., Luo Y., Hickey R. W., Chen J., TAT-mediated delivery of Bcl-xL protein is neuroprotective against neonatal hypoxic-ischemic brain injury via inhibition of caspases and AIF. Neurobiology of Disease 2006 21 2 358 371 2-s2.0-30744434357 10.1016/j.nbd.2005.07.015 (Pubitemid 43099859)
75. Parsadanian A. S., Cheng Y., Keller-Peck C. R., Holtzman D. M., Snider W. D., Bcl-x(L) is an antiapoptotic regulator for postnatal CNS neurons. Journal of Neuroscience 1998 18 3 1009 1019 2-s2.0-0031594505 (Pubitemid 28112923)
76. Wang X., Han W., Du X., Zhu C., Carlsson Y., Mallard C., Jacotot E., Hagberg H., Neuroprotective effect of Bax-inhibiting peptide on neonatal brain injury. Stroke 2010 41 9 2050 2055 2-s2.0-77956410991 10.1161/STROKEAHA.110. 589051
77. Vousden K. H., Prives C., Blinded by the light: The growing complexity of p53. Cell 2009 137 3 413 431 2-s2.0-65349103899 10.1016/j.cell.2009.04.037
78. Morrison R. S., Kinoshita Y., Johnson M. D., Guo W., Garden G. A., p53-dependent cell death signaling in neurons. Neurochemical Research 2003 28 1 15 27 2-s2.0-0037263789 10.1023/A:1021687810103 (Pubitemid 36173223)
79. Green D. R., Kroemer G., Cytoplasmic functions of the tumour suppressor p53. Nature 2009 458 7242 1127 1130 2-s2.0-65949083750 10.1038/nature07986
80. Honda R., Tanaka H., Yasuda H., Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Letters 1997 420 1 25 27 2-s2.0-0031583962 10.1016/S0014-5793(97)01480-4 (Pubitemid 28037193)
81. Riley T., Sontag E., Chen P., Levine A., Transcriptional control of human p53-regulated genes. Nature Reviews Molecular Cell Biology 2008 9 5 402 412 2-s2.0-42449114966 10.1038/nrm2395 (Pubitemid 351574202)
82. Chipuk J. E., Bouchier-Hayes L., Kuwana T., Newmeyer D. D., Green D. R., Cell biology: PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 2005 309 5741 1732 1735 2-s2.0-24644436766 10.1126/science.1114297 (Pubitemid 41285944)
83. Nijboer C. H. A., Heijnen C. J., Groenendaal F., May M. J., van Bel F., Kavelaars A., Strong neuroprotection by inhibition of NF- μ °B after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke 2008 39 7 2129 2137 2-s2.0-47649096803 10.1161/STROKEAHA.107. 504175
84. Nijboer C. H., Heijnen C. J., Groenendaal F., May M. J., van Bel F., Kavelaars A., A dual role of the nf-kappa b pathway in neonatal hypoxic-ischemic brain damage. Stroke 2008 39 9 2578 2586 2-s2.0-52449126395 10.1161/STROKEAHA.108.516401
85. van der Kooij M. A., Nijboer C. H., Ohl F., Groenendaal F., Heijnen C. J., van Bel F., Kavelaars A., NF- κ B inhibition after neonatal cerebral hypoxia-ischemia improves long-term motor and cognitive outcome in rats. Neurobiology of Disease 2010 38 2 266 272 2-s2.0-77951208719 10.1016/j.nbd.2010.01.016
86. Nijboer C. H., Heijnen C. J., van der Kooij M. A., Zijlstra J., van Velthoven C. T. J., Culmsee C., van Bel F., Hagberg H., Kavelaars A., A.Kavelaars@umcutrecht.nl Targeting the p53 pathway to protect the neonatal ischemic brain. Annals of Neurology 2011 70 2 255 264 10.1002/ana.22413
87. Strom E., Sathe S., Komarov P. G., Chernova O. B., Pavlovska I., Shyshynova I., Bosykh D. A., Burdelya L. G., Macklis R. M., Skaliter R., Komarova E. A., Gudkov A. V., Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nature Chemical Biology 2006 2 9 474 479 2-s2.0-33747620737 10.1038/nchembio809 (Pubitemid 44266309)
88. Dreskin S. C., Thomas G. W., Dale S. N., Heasley L. E., Isoforms of jun kinase are differentially expressed and activated in human monocyte/macrophage (THP-1) cells1. Journal of Immunology 2001 166 9 5646 5653 2-s2.0-0035339885 (Pubitemid 32374188)
89. Kuan C. Y., Whitmarsh A. J., Yang D. D., Liao G., Schloemer A. J., Dong C., Bao J., Banasiak K. J., Haddad G. G., Flavell R. A., Davis R. J., Rakic P., A critical role of neural-specific JNK3 for ischemic apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2003 100 25 15184 15189 2-s2.0-10744229507 10.1073/pnas.2336254100 (Pubitemid 37518037)
90. Pirianov G., Brywe K. G., Mallard C., Edwards D., Flavell R. A., Hagberg H., Mehmet H., Deletion of the c-Jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxic-ischaemic injury. Journal of Cerebral Blood Flow and Metabolism 2007 27 5 1022 1032 2-s2.0-34247503156 10.1038/sj.jcbfm.9600413 (Pubitemid 46659033)
91. Herdegen T., Claret F. X., Kallunki T., Martin-Villalba A., Winter C., Hunter T., Karin M., Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N- terminal kinases after neuronal injury. Journal of Neuroscience 1998 18 14 5124 5135 2-s2.0-0032527879 (Pubitemid 28311930)
92. Kumar S., Kinoshita M., Noda M., Copeland N. G., Jenkins N. A., Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 β -converting enzyme. Genes and Development 1994 8 14 1613 1626 2-s2.0-0027990778 (Pubitemid 24236241)
93. Duan H., Dixit V. M., RAIDD is a new 'death' adaptor molecule. Nature 1997 385 6611 86 89 2-s2.0-0031021356 10.1038/385086a0 (Pubitemid 27024560)
94. Baliga B. C., Read S. H., Kumar S., The biochemical mechanism of caspase-2 activation. Cell Death and Differentiation 2004 11 11 1234 1241 2-s2.0-8844224859 10.1038/sj.cdd.4401492 (Pubitemid 39529966)
95. Tinel A., Tschopp J., The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004 304 5672 843 846 2-s2.0-2442453730 10.1126/science.1095432 (Pubitemid 38620177)
96. Lassus P., Opitz-Araya X., Lazebnik Y., Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 2002 297 5585 1352 1354 2-s2.0-0037162833 10.1126/science.1074721 (Pubitemid 34913174)
97. Carlsson Y., Schwendimann L., Vontell R., Rousset C. I., Wang X., Lebon S., Charriaut-Marlangue C., Supramaniam V., Hagberg H., Gressens P., pierre.gressens@inserm.fr Jacotot E., ejacotot@imperial.ac.uk Genetic inhibition of caspase-2 reduces hypoxic-ischemic and excitotoxic neonatal brain injury. Annals of Neurology 2011 70 5 781 789 10.1002/ana.22431
98. Bergeron L., Perez G. I., Macdonald G., Shi L., Sun Y., Jurisicova A., Varmuza S., Latham K. E., Flaws J. A., Salter J. C. M., Hara H., Moskowitz M. A., Li E., Greenberg A., Tilly J. L., Yuan J., Defects in regulation of apoptosis in caspase-2-deficient mice. Genes and Development 1998 12 9 1304 1314 2-s2.0-0032080197 (Pubitemid 28213406)
99. Chauvier D., Renolleau S., Holifanjaniaina S., Ankri S., Bezault M., Schwendimann L., Rousset C., Casimir R., Hoebeke J., Smirnova M., Debret G., Trichet A.-P., Carlsson Y., Wang X., Bernard E., Hé Bert M., Rauzier J.-M., Matecki S., Lacampagne A., Rustin P., Mariani J., Hagberg H., Gressens P., Charriaut-Marlangue C., Jacotot E., etienne.jacotot@inserm.fr Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor. Cell Death and Disease 2011 2 9, article e203 10.1038/cddis.2011.87
100. Jin Y., Silverman A. J., Vannucci S. J., Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke 2009 40 9 3107 3112 2-s2.0-70349237576 10.1161/STROKEAHA.109.549691
101. Hagberg H., Mallard C., Effect of inflammation on central nervous system development and vulnerability. Current Opinion in Neurology 2005 18 2 117 123 2-s2.0-16444378016 (Pubitemid 40477485)
102. Bona E., Andersson A. L., Blomgren K., Gilland E., Puka-Sundvall M., Gustafson K., Hagberg H., Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatric Research 1999 45 4 500 509 2-s2.0-0032940020 (Pubitemid 29162729)
103. Taylor D. L., Jones F., Chen Seho Kubota E. S. F., Pocock J. M., Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor α -induced neurotoxicity in concert with microglial-derived Fas ligand. Journal of Neuroscience 2005 25 11 2952 2964 2-s2.0-15244350494 10.1523/JNEUROSCI.4456-04.2005 (Pubitemid 40389253)
104. Hoffmann O., Zipp F., Weber J. R., Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation. Journal of Molecular Medicine 2009 87 8 753 763 2-s2.0-70349243807 10.1007/s00109-009-0484-x
105. Yepes M., Brown S. A. N., Moore E. G., Smith E. P., Lawrence D. A., Winkles J. A., A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia. American Journal of Pathology 2005 166 2 511 520 2-s2.0-13244257271 (Pubitemid 40189047)
106. Edwards A. D., Yue X., Cox P., Hope P. L., Azzopardi D. V., Squier M. V., Mehmet H., Apoptosis in the brains of infants suffering intrauterine cerebral injury. Pediatric Research 1997 42 5 684 689 2-s2.0-0030727371 (Pubitemid 27459479)
107. Pennica D., Nedwin G. E., Hayflick J. S., Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984 312 5996 724 729 2-s2.0-0021681058 (Pubitemid 15195918)
108. Love S., Apoptosis and brain ischaemia. Progress in Neuro- Psychopharmacology and Biological Psychiatry 2003 27 2 267 282 2-s2.0-0037377137 10.1016/S0278-5846(03)00022-8 (Pubitemid 36351494)
109. Sugawara T., Fujimura M., Noshita N., Kim G. W., Saito A., Hayashi T., Narasimhan P., Maier C. M., Chan P. H., Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx 2004 1 1 17 25 2-s2.0-7644238227 10.1602/neurorx.1.1.17 (Pubitemid 46589339)
110. Vandenabeele P., Galluzzi L., Vanden Berghe T., Kroemer G., Molecular mechanisms of necroptosis: an ordered cellular explosion. Nature Reviews Molecular Cell Biology 2010 11 10 700 714 2-s2.0-77957105977 10.1038/nrm2970
111. Tartaglia L. A., Weber R. F., Figari I. S., Reynolds C., Palladino M. A., Goeddel D. V., The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proceedings of the National Academy of Sciences of the United States of America 1991 88 20 9292 9296 2-s2.0-0026072837 (Pubitemid 21915617)
112. Dziewulska D., Mossakowski M. J., Cellular expression of tumor necrosis factor α and its receptors in human ischemic stroke. Clinical Neuropathology 2003 22 1 35 40 2-s2.0-0037254083 (Pubitemid 36152123)
113. Figiel I., Dzwonek K., TNF α and TNF receptor 1 expression in the mixed neuronal-glial cultures of hippocampal dentate gyrus exposed to glutamate or trimethyltin. Brain Research 2007 1131 1 17 28 2-s2.0-33846005877 10.1016/j.brainres.2006.10.095 (Pubitemid 46053896)
114. Dopp J. M., Mackenzie-Graham A., Otero G. C., Merrill J. E., Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. Journal of Neuroimmunology 1997 75 1-2 104 112 2-s2.0-0030996264 10.1016/S0165-5728(97)00009-X (Pubitemid 27170308)
115. Dembic Z., Loetscher H., Gubler U., Pan Y. C. E., Lahm H. W., Gentz R., Brockhaus M., Lesslauer W., Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 1990 2 4 231 237 2-s2.0-0025463156
116. Marchetti L., Klein M., Schlett K., Pfizenmaier K., Eisel U. L. M., Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation: essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF- κ B pathway. The Journal of Biological Chemistry 2004 279 31 32869 32881 2-s2.0-3543046113 10.1074/jbc.M311766200 (Pubitemid 39014747)
117. Hsu H., Xiong J., Goeddel D. V., The TNF receptor 1-associated protein TRADD signals cell death and NF- κ B activation. Cell 1995 81 4 495 504 2-s2.0-0029007855
118. Song H. Y., Régnier C. H., Kirschning C. J., Goeddel D. V., Rothe M., Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor- κ B and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proceedings of the National Academy of Sciences of the United States of America 1997 94 18 9792 9796 2-s2.0-12644272789 10.1073/pnas.94.18.9792 (Pubitemid 27408143)
119. Nelson K. B., Dambrosia J. M., Grether J. K., Phillips T. M., Neonatal cytokines and coagulation factors in children with cerebral palsy. Annals of Neurology 1998 44 4 665 675 2-s2.0-0031783968 10.1002/ana.410440413 (Pubitemid 28477855)
120. Markus T., Tina.Markus@med.lu.se Cronberg T., Cilio C., Pronk C., Wieloch T., Ley D., Tumor necrosis factor receptor-1 is essential for LPS-induced sensitization and tolerance to oxygen-glucose deprivation in murine neonatal organotypic hippocampal slices. Journal of Cerebral Blood Flow and Metabolism 2009 29 1 73 86 10.1038/jcbfm.2008.90
121. Kendall G. S., g.kendall@ucl.ac.uk Hirstova M., Horn S., Dafou D., Acosta-Saltos A., Almolda B., Zbarsky V., Rumajogee P., Heuer H., Castellano B., Pfeffer K., Nedospasov S. A., Peebles D. M., Raivich G., TNF gene cluster deletion abolishes lipopolysaccharide-mediated sensitization of the neonatal brain to hypoxic ischemic insult. Laboratory Investigation 2011 91 3 328 341 10.1038/labinvest.2010.192
122. Yu C., Takeda M., Soliven B., Regulation of cell cycle proteins by TNF- α and TGF- β in cells of oligodendroglial lineage. Journal of Neuroimmunology 2000 108 1-2 2 10 2-s2.0-0034255930 10.1016/S0165-5728(99)00278- 7 (Pubitemid 30438745)
123. Andrews T., Zhang P., Bhat N. R., bhatnr@musc.edu TNF α potentiates IFN γ -induced cell death in oligodendrocyte progenitors. Journal of Neuroscience Research 1998 54 5 574 583 (Pubitemid 28546060)
124. Selmaj K. W., Farooq M., Norton W. T., Raine C. S., Brosnan C. F., Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. Journal of Immunology 1990 144 1 129 135
125. Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., Sonobe Y., Mizuno T., Suzumura A., Tumor necrosis factor- α induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. The Journal of Biological Chemistry 2006 281 30 21362 21368 2-s2.0-33746354022 10.1074/jbc.M600504200 (Pubitemid 44115475)
126. Bruce A. J., Boling W., Kindy M. S., Peschon J., Kraemer P. J., Carpenter M. K., Holtsberg F. W., Mattson M. P., Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Medicine 1996 2 7 788 794 2-s2.0-0029899586 10.1038/nm0796-788 (Pubitemid 26225095)
127. Lambertsen K. L., Clausen B. H., Babcock A. A., Gregersen R., Fenger C., Nielsen H. H., Haugaard L. S., Wirenfeldt M., Nielsen M., Dagnaes-Hansen F., Bluethmann H., Færgeman N. J., Meldgaard M., Deierborg T., Finsen B., Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. Journal of Neuroscience 2009 29 5 1319 1330 2-s2.0-59649117102 10.1523/JNEUROSCI.5505-08.2009
128. Pitti R. M., Marsters S. A., Lawrence D. A., Roy M., Kischkel F. C., Dowd P., Huang A., Donahue C. J., Sherwood S. W., Baldwin D. T., Godowski P. J., Wood W. I., Gurney A. L., Hillan K. J., Cohen R. L., Goddard A. D., Botstein D., Ashkenazi A., Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998 396 6712 699 703 2-s2.0-17444424930 10.1038/25387 (Pubitemid 29003951)
129. Martin-Villalba A., Herr I., Jeremias I., Hahne M., Brandt R., Vogel J., Schenkel J., Herdegen T., Debatin K. M., CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis- inducing ligand mediate ischemia-induced apoptosis in neurons. Journal of Neuroscience 1999 19 10 3809 3817 2-s2.0-0033562658 (Pubitemid 29222257)
130. Rosenbaum D. M., Gupta G., D'Amore J., Singh M., Weidenheim K., Zhang H., Kessler J. A., Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemia. Journal of Neuroscience Research 2000 61 6 686 692 2-s2.0-0034666684 10.1002/1097-4547(20000915)61:6686::AID-JNR12>3.0.CO;2-7
131. Northington F. J., Ferriero D. M., Flock D. L., Martin L. J., Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. Journal of Neuroscience 2001 21 6 1931 1938 2-s2.0-0035869339 (Pubitemid 32221377)
132. Felderhoff-Mueser U., Taylor D. L., Greenwood K., Kozma M., Stibenz D., Joashi U. C., Edwards A. D., Mehmet H., Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is upregulated following cerebral hypoxic-ischemic injury to the developing rat brain. Brain Pathology 2000 10 1 17 29 2-s2.0-0033968517 (Pubitemid 30056390)
133. Graham E. M., Sheldon R. A., Flock D. L., Ferriero D. M., Martin L. J., O'Riordan D. P., Northington F. J., Neonatal mice lacking functional Fas death receptors are resistant to hypoxic-ischemic brain injury. Neurobiology of Disease 2004 17 1 89 98 2-s2.0-4444377604 10.1016/j.nbd.2004.05.007 (Pubitemid 39209316)
134. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., Bodmer J. L., Schneider P., Seed B., Tschopp J., Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunology 2000 1 6 489 495 2-s2.0-5944233768
135. Matsumura H., Shimizu Y., Ohsawa Y., Kawahara A., Uchiyama Y., Nagata S., Necrotic death pathway in Fas receptor signaling. Journal of Cell Biology 2000 151 6 1247 1255 2-s2.0-0034638827 10.1083/jcb.151.6.1247
136. Lambert C., Landau A. M., Desbarats J., Fasbeyond death: a regenerative role for Fas in the nervous system. Apoptosis 2003 8 6 551 562 2-s2.0-0242636280 10.1023/A:1026113222478 (Pubitemid 37411739)
137. Pan G., O'Rourke K., Chinnaiyan A. M., Gentz R., Ebner R., Ni J., Dixit V. M., The receptor for the cytotoxic ligand TRAIL. Science 1997 276 5309 111 113 2-s2.0-0030996297 10.1126/science.276.5309.111 (Pubitemid 27161256)
138. Walczak H., Degli-Esposti M. A., Johnson R. S., Smolak P. J., Waugh J. Y., Boiani N., Timour M. S., Gerhart M. J., Schooley K. A., Smith C. A., Goodwin R. G., Rauch C. T., TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. The EMBO Journal 1997 16 17 5386 5397 2-s2.0-0030880548 10.1093/emboj/16.17.5386 (Pubitemid 27380146)
139. Sheridan J. P., Marsters S. A., Pitti R. M., Gurney A., Skubatch M., Baldwin D., Ramakrishnan L., Gray C. L., Baker K., Wood W. I., Goddard A. D., Godowski P., Ashkenazi A., Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997 277 5327 818 821 2-s2.0-0030792712 10.1126/science.277.5327.818 (Pubitemid 27366733)
140. Marsters S. A., Sheridan J. P., Pitti R. M., Huang A., Skubatch M., Baldwin D., Yuan J., Gurney A., Goddard A. D., Godowski P., Ashkenazi A., A novel receptor for Apo2L/TRAIL contains a truncated death domain. Current Biology 1997 7 12 1003 1006 2-s2.0-13144265771 (Pubitemid 28017080)
141. Emery J. G., McDonnell P., Burke M. B., Deen K. C., Lyn S., Silverman C., Dul E., Appelbaum E. R., Eichman C., DiPrinzio R., Dodds R. A., James I. E., Rosenberg M., Lee J. C., Young P. R., Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. The Journal of Biological Chemistry 1998 273 23 14363 14367 2-s2.0-7344233085 10.1074/jbc.273.23.14363 (Pubitemid 28319153)
142. Bossen C., Ingold K., Tardivel A., Bodmer J. L., Gaide O., Hertig S., Ambrose C., Tschopp J., Schneider P., Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. The Journal of Biological Chemistry 2006 281 20 13964 13971 2-s2.0-33744944082 10.1074/jbc.M601553200 (Pubitemid 43848322)
143. Schneider P., Olson D., Tardivel A., Browning B., Lugovskoy A., Gong D., Dobles M., Hertig S., Hofmann K., van Vlijmen H., Hsu Y. M., Burkly L. C., Tschopp J., Zheng T. S., Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). The Journal of Biological Chemistry 2003 278 7 5444 5454 2-s2.0-0038751850 10.1074/jbc.M210783200 (Pubitemid 36801061)
144. Wu G. S., Burns T. F., Zhan Y., Alnemri E. S., El-Deiry W. S., Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Cancer Research 1999 59 12 2770 2775 2-s2.0-0001203366 (Pubitemid 29283105)
145. Wiley S. R., Cassiano L., Lofton T., Davis-Smith T., Winkles J. A., Lindner V., Liu H., Daniel T. O., Smith C. A., Fanslow W. C., A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 2001 15 5 837 846 2-s2.0-18244380611 10.1016/S1074-7613(01)00232-1 (Pubitemid 34008510)
146. Winkles J. A., The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nature Reviews Drug Discovery 2008 7 5 411 425 2-s2.0-42949160019 10.1038/nrd2488 (Pubitemid 351619113)
147. Nakayama M., Ishidoh K., Kayagaki N., Kojima Y., Yamaguchi N., Nakano H., Kominami E., Okumura K., Yagita H., Multiple pathways of TWEAK-induced cell death. Journal of Immunology 2002 168 2 734 743 2-s2.0-0037080352 (Pubitemid 34049574)
148. Potrovita I., Zhang W., Burkly L., Hahm K., Lincecum J., Wang M. Z., Maurer M. H., Rossner M., Schneider A., Schwaninger M., Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration. Journal of Neuroscience 2004 24 38 8237 8244 2-s2.0-4644228323 10.1523/JNEUROSCI.1089-04. 2004 (Pubitemid 39280803)
149. Cannella B., Gaupp S., Omari K. M., Raine C. S., Multiple sclerosis: death receptor expression and oligodendrocyte apoptosis in established lesions. Journal of Neuroimmunology 2007 188 1-2 128 137 2-s2.0-34447637949 10.1016/j.jneuroim.2007.05.018 (Pubitemid 47095021)
150. Cui M., Wang L., Liang X., Ma X., Liu Y., Yang M., Liu K., Wei X., Zhou Z., Chen Y. H., Sun W., Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia. Neurobiology of Disease 2010 39 2 138 147 2-s2.0-77953717800 10.1016/j.nbd.2010.03.018
151. Favrais G., van de Looij Y., Fleiss B., Ramanantsoa N., Bonnin P., Stoltenburg-Didinger G., Lacaud A., Saliba E., Dammann O., Gallego J., Sizonenko S., Hagberg H., Lelièvre V., Gressens P., pierre.gressens@inserm.fr Systemic inflammation disrupts the developmental program of white matter. Annals of Neurology 2011 70 4 550 565 10.1002/ana.22489
152. Galic M. A., Riazi K., Heida J. G., Mouihate A., Fournier N. M., Spencer S. J., Kalynchuk L. E., Teskey G. C., Pittman Q. J., Postnatal inflammation increases seizure susceptibility in adult rats. Journal of Neuroscience 2008 28 27 6904 6913 2-s2.0-49049097966 10.1523/JNEUROSCI.1901-08.2008
153. Spencer S. J., spences@ucalgary.ca Auer R. N., Pittman Q. J., Rat neonatal immune challenge alters adult responses to cerebral ischaemia. Journal of Cerebral Blood Flow and Metabolism 2006 26 4 456 467 10.1038/sj.jcbfm.9600206
154. Bilbo S. D., Barrientos R. M., Eads A. S., Northcutt A., Watkins L. R., Rudy J. W., Maier S. F., Early-life infection leads to altered BDNF and IL-1 β mRNA expression in rat hippocampus following learning in adulthood. Brain, Behavior, and Immunity 2008 22 4 451 455 2-s2.0-41349099144 10.1016/j.bbi.2007.10.003 (Pubitemid 351451825)
155. Lin C. Y., Chang Y. C., Wang S. T., Lee T. Y., Lin C. F., Huang C. C., Altered inflammatory responses in preterm children with cerebral palsy. Annals of Neurology 2010 68 2 204 212 2-s2.0-77955292676 10.1002/ana.22049
156. Nagamoto-Combs K., McNeal D. W., Morecraft R. J., Combs C. K., Prolonged microgliosis in the rhesus monkey central nervous system after traumatic brain injury. Journal of Neurotrauma 2007 24 11 1719 1742 2-s2.0-39449125357 10.1089/neu.2007.0377 (Pubitemid 351267796)
157. Annegers J. F., Rocca W. A., Causes of epilepsy: contributions of the rochester epidemiology project. Mayo Clinic Proceedings 1996 71 6 570 575 2-s2.0-0030317376
158. Limperopoulos C., Bassan H., Sullivan N. R., Soul J. S., Robertson R. L., Moore M., Ringer S. A., Volpe J. J., Plessis A. J. D., Positive screening for autism in ex-preterm infants: prevalence and risk factors. Pediatrics 2008 121 4 758 765 2-s2.0-42949115964 10.1542/peds.2007-2158
159. Meyer U., urmeyer@ethz.ch Feldon J., Dammann O., Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatric Research 2011 69 5, part 2 26R 33R 10.1203/PDR. 0b013e318212c196
160. Thoresen M., marianne.thoresen@bris.ac.uk Cooling the newborn after asphyxiaphysiological and experimental background and its clinical use. Seminars in Neonatology 2000 5 1 61 73 10.1053/siny.1999.0118 (Pubitemid 30159179)
161. Liu Y., Barks J. D., Xu G., Silverstein F. S., Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 2004 35 6 1460 1465 2-s2.0-2542527103 10.1161/01.STR. 0000128029.50221.fa (Pubitemid 38697476)
162. Barks J. D., Liu Y. Q., Shangguan Y., Silverstein F. S., Phenobarbital augments hypothermic neuroprotection. Pediatric Research 2010 67 5 532 537 2-s2.0-77951488224 10.1203/PDR.0b013e3181d4ff4d
163. Ma D., Hossain M., Chow A., Arshad M., Battson R. M., Sanders R. D., Mehmet H., Edwards A. D., Franks N. P., Maze M., Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Annals of Neurology 2005 58 2 182 193 2-s2.0-23244461697 10.1002/ana.20547 (Pubitemid 41098876)
164. Faulkner S., Bainbridge A., Kato T., Chandrasekaran M., Kapetanakis A. B., Hristova M., Liu M., Evans S., De Vita E., Kelen D., Sanders R. D., Edwards A. D., Maze M., Cady E. B., Raivich G., Robertson N. J., n.robertson@ucl.ac.uk Xenon augmented hypothermia reduces early lactate/N-acetylaspartate and cell death in perinatal asphyxia. Annals of Neurology 2011 70 1 133 150 10.1002/ana.22387
165. Rogido M., Husson I., Bonnier C., Lallemand M. C., Mérienne C., Gregory G. A., Sola A., Gressens P., Fructose-1,6-biphosphate prevents excitotoxic neuronal cell death in the neonatal mouse brain. Developmental Brain Research 2003 140 2 287 297 2-s2.0-12244310548 10.1016/S0165-3806(02)00615-6 (Pubitemid 36173985)
166. Ramlackhansingh A. F., Brooks D. J., Greenwood R. J., Bose S. K., Turkheimer F. E., Kinnunen K. M., Gentleman S., Heckemann R. A., Gunanayagam K., Gelosa G., Sharp D. J., david.sharp@imperial.ac.uk Inflammation after trauma: microglial activation and traumatic brain injury. Annals of Neurology 2011 70 3 374 383 10.1002/ana.22455
167. Weaver I. C. G., Cervoni N., Champagne F. A., D'Alessio A. C., Sharma S., Seckl J. R., Dymov S., Szyf M., Meaney M. J., Epigenetic programming by maternal behavior. Nature Neuroscience 2004 7 8 847 854 2-s2.0-3342989681 10.1038/nn1276 (Pubitemid 38989508)
168. Ren M., Leng Y., Jeong M., Leeds P. R., Chuang D. M., Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. Journal of Neurochemistry 2004 89 6 1358 1367 2-s2.0-3042651448 10.1111/j.1471-4159.2004.02406.x (Pubitemid 38802657)
169. Faraco G., Pancani T., Formentini L., Mascagni P., Fossati G., Leoni F., Moroni F., Chiarugi A., Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Molecular Pharmacology 2006 70 6 1876 1884 2-s2.0-33751120697 10.1124/mol.106.027912 (Pubitemid 44771903)
170. Ke X., Lei Q., James S. J., Kelleher S. L., Melnyk S., Jernigan S., Yu X., Wang L., Callaway C. W., Gill G., Chan G. M., Albertine K. H., McKnight R. A., Lane R. H., Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats. Physiological Genomics 2006 25 1 16 28 2-s2.0-33645755191 10.1152/physiolgenomics.00093.2005
171. Shen S., Liu A., Li J., Wolubah C., Casaccia-Bonnefil P., Epigenetic memory loss in aging oligodendrocytes in the corpus callosum. Neurobiology of Aging 2008 29 3 452 463 2-s2.0-38949136675 10.1016/j.neurobiolaging.2006.10.026 (Pubitemid 351215588)
172. Jai S. N., Sharma R. P., Veldic M., Salvacion A. A., Jia X., Chen Y., Costa E., Guidotti A., Grayson D. R., DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proceedings of the National Academy of Sciences of the United States of America 2005 102 5 1749 1754 2-s2.0-13444271572 10.1073/pnas.0409648102 (Pubitemid 40209239)
173. Yakovlev A., Khafizova M., Abdullaev Z., Loukinov D., Kondratyev A., Epigenetic regulation of caspase-3 gene expression in rat brain development. Gene 2010 450 1-2 103 108 2-s2.0-72449176834 10.1016/j.gene.2009.10.008 36651
174. Liu J., Casaccia P., Epigenetic regulation of oligodendrocyte identity. Trends in Neurosciences 2010 33 4 193 201 2-s2.0-77950867183 10.1016/j.tins.2010.01.007
175. Ye F., Chen Y., Hoang T., Montgomery R. L., Zhao X. H., Bu H., Hu T., Taketo M. M., van Es J. H., Clevers H., Hsieh J., Bassel-Duby R., Olson E. N., Lu Q. R., HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nature Neuroscience 2009 12 7 829 838 2-s2.0-67649797866 10.1038/nn.2333
176. Dharap A., Bowen K., Place R., Li L.-C., Vemuganti R., vemugant@neurosurg.wisc.edu Transient focal ischemia induces extensive temporal changes in rat cerebral MicroRNAome. Journal of Cerebral Blood Flow and Metabolism 2009 29 4 675 687 10.1038/jcbfm.2008.157
177. Ponomarev E. D., Veremeyko T., Barteneva N., Krichevsky A. M., Weiner H. L., MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP- α -PU.1 pathway. Nature Medicine 2010 17 1 64 70 2-s2.0-78649559558 10.1038/nm.2266
178. Gibson C. L., Murphy S. P., Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies. Journal of Neurochemistry 2010 115 4 806 813 2-s2.0-77958544846 10.1111/j.1471-4159.2010. 06993.x
179. Kabakus N., Ay I., Aysun S., Söylemezoglu F., Özcan A., Celasun B., Protective effects of valproic acid against hypoxic-ischemic brain injury in neonatal rats. Journal of Child Neurology 2005 20 7 582 587 2-s2.0-24344433954 (Pubitemid 41245800)
180. Weaver I. C. G., Champagne F. A., Brown S. E., Dymov S., Sharma S., Meaney M. J., michael.meaney@mcgill.ca Szyf M., moshe.szyf@mcgill.ca Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. Journal of Neuroscience 2005 25 47 11045 11054 10.1523/JNEUROSCI.3652-05.2005 (Pubitemid 41692634)
181. Colton C. A., Heterogeneity of microglial activation in the innate immune response in the brain. Journal of Neuroimmune Pharmacology 2009 4 4 399 418 2-s2.0-70449526190 10.1007/s11481-009-9164-4
182. Colton C. A., Wilcock D. M., Assessing activation states in microglia. CNS and Neurological DisordersDrug Targets 2010 9 2 174 191 2-s2.0-77949901284
183. Lalancette-Hébert M., Gowing G., Simard A., Yuan C. W., Kriz J., Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. Journal of Neuroscience 2007 27 10 2596 2605 2-s2.0-33847785649 10.1523/JNEUROSCI.5360-06.2007 (Pubitemid 46393607)
184. Madinier A., Bertrand N., Mossiat C., Prigent-Tessier A., Beley A., Marie C., Garnier P., Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS One 2009 4 12 2-s2.0-77953992774 10.1371/journal.pone.0008101 e8101
185. Mikita J., Dubourdieu-Cassagno N., Deloire M. S., Vekris A., Biran M., Raffard G., Brochet B., Canron M.-H., Franconi J.-M., Boiziau C., claudine.boiziau@inserm.fr Petry K. G., Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Multiple Sclerosis 2011 17 1 2 15 10.1177/1352458510379243
186. Titomanlio L., Bouslama M., Le Verche V., Dalous J., Kaindl A. M., Tsenkina Y., Lacaud A., Peineau S., Ghouzzi V. E., Lelièvre V., lelievre@inci-cnrs.unistra.fr Gressens P., Implanted neurosphere-derived precursors promote recovery after neonatal excitotoxic brain injury. Stem Cells and Development 2011 20 5 865 879 10.1089/scd.2010.0302
187. Zhang L., Li Y., Zhang C., Chopp M., michael.chopp@gmail.com Gosiewska A., Hong K., Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Stroke 2011 42 5 1437 1444 10.1161/STROKEAHA.110.593129
188. Baud O., Daire J. L., Dalmaz Y., Fontaine R. H., Krueger R. C., Sebag G., Evrard P., Gressens P., Verney C., Gestational hypoxia induces white matter damage in neonatal rats: a new model of periventricular leukomalacia. Brain Pathology 2004 14 1 1 10 2-s2.0-1042299973 (Pubitemid 38200584)
189. Delcour M., Olivier P., Chambon C., Pansiot J., Russier M., Liberge M., Xin D., Gestreau C., Alescio-Lautier B., Gressens P., Verney C., Barbe M. F., Baud O., olivier.baud@rdb.aphp.fr Coq J.-O., Neuroanatomical, sensorimotor and cognitive deficits in adult rats with white matter injury following prenatal ischemia. Brain Pathology 2012 22 1 1 16 10.1111/j.1750-3639.2011.00504.x
190. Perlman J. M., White matter injury in the preterm infant: an important determination of abnormal neurodevelopment outcome. Early Human Development 1998 53 2 99 120 2-s2.0-0032404075 10.1016/S0378-3782(98)00037-1 (Pubitemid 28517940)
191. Rousset C. I., Chalon S., Cantagrel S., Bodard S., Andres C., Gressens P., Saliba E., Maternal exposure to LPS induces hypomyelination in the internal capsule and programmed cell death in the deep gray matter in newborn rats. Pediatric Research 2006 59 3 428 433 2-s2.0-33646111717 10.1203/01.pdr. 0000199905.08848.55 (Pubitemid 43740083)
192. Tonnesen J., Parish C. L., Sorensen A. T., Andersson A., Lundberg C., Deisseroth K., Arenas E., Lindvall O., Kokaia M., Merab.Kokaia@med.lu.se Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model. PLoS One 2011 6 3 e17560 10.1371/journal.pone.0017560
193. Carroll J. E., JCARROLL@mail.mcg.edu Mays R. W., Update on stem cell therapy for cerebral palsy. Expert Opinion on Biological Therapy 2011 11 4 463 471 10.1517/14712598.2011.557060
194. Covey M. V., Jiang Y., Alli V. V., Yang Z., Levison S. W., Defining the critical period for neocortical neurogenesis after pediatric brain injury. Developmental Neuroscience 2010 32 5-6 488 498 2-s2.0-78650061690 10.1159/000321607
195. Holtzman D. M., Sheldon R. A., Jaffe W., Cheng Y., Ferriero D. M., Nerve growth factor protects the neonatal brain against hypoxic-ischemic injury. Annals of Neurology 1996 39 1 114 122 2-s2.0-0030053351 10.1002/ana.410390117 (Pubitemid 26052225)
196. Johnston B. M., Mallard E. C., Williams C. E., Gluckman P. D., Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-lschemic injury in fetal lambs. The Journal of Clinical Investigation 1996 97 2 300 308 2-s2.0-0030071176
197. Gressens P., Marret S., Hill J. M., Brenneman D. E., Gozes I., Fridkin M., Evrard P., Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. The Journal of Clinical Investigation 1997 100 2 390 397 2-s2.0-0030751248 (Pubitemid 27349086)
198. Husson I., Rangon C. M., Lelièvre V., Bemelmans A. P., Sachs P., Mallet J., Kosofsky B. E., Gressens P., BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cerebral Cortex 2005 15 3 250 261 2-s2.0-13944275211 10.1093/cercor/bhh127 (Pubitemid 40270194)
199. Osredkar D., Sall J. W., Bickler P. E., Ferriero D. M., Erythropoietin promotes hippocampal neurogenesis in in vitro models of neonatal stroke. Neurobiology of Disease 2010 38 2 259 265 2-s2.0-77951206148 10.1016/j.nbd.2010.01.015
200. Destot-Wong K. D., Liang K., Gupta S. K., Favrais G., Schwendimann L., Pansiot J., Baud O., Spedding M., Lelièvre V., Mani S., Gressens P., The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis. Neuropharmacology 2009 57 3 277 286 2-s2.0-67651004686 10.1016/j.neuropharm. 2009.05.010
201. Welin A. K., Svedin P., Lapatto R., Sultan B., Hagberg H., Gressens P., Kjellmer I., Mallard C., Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatric Research 2007 61 2 153 158 2-s2.0-33846463411 10.1203/01.pdr. 0000252546.20451.1a (Pubitemid 46146871)
202. Gitto E., Reiter R. J., Amodio A., Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. Journal of Pineal Research 2004 36 4 250 255 2-s2.0-11144355886 10.1111/j.1600-079X.2004.00124.x (Pubitemid 38530472)
203. MRC (Ongoing), Melatonin as a Novel Neuroprotectant in Preterm.
204. Zhu C., Kang W., Xu F., Cheng X., Zhang Z., Jia L., Ji L., Guo X., Xiong H., Simbruner G., Blomgren K., Wang X., Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009 124 2 e218 e226 2-s2.0-67749137294 10.1542/peds.2008-3553